| European Case Law Identifier: | ECLI:EP:BA:2009:T205208.20090203 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 03 February 2009 | ||||||||
| Case number: | T 2052/08 | ||||||||
| Application number: | 97923186.7 | ||||||||
| IPC class: | C12Q 1/68 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Methods for identifying a mutation in a gene of interest | ||||||||
| Applicant name: | Ingenium Pharmaceuticals GmbH | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Transitional provisions of the EPC 2000 Reimbursement of appeal fee pursuant to Rule 103(1)(b) EPC (yes) |
||||||||
| Catchwords: |
see points 2 to 6 of the reasons |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t082052eu1.html
Date retrieved: 17 May 2021
